Navigation Links
Amifostine Renders Cancer More Susceptible To Radiation

The drug amifostine has been found to ease most of the side affects associated with radiation therapy and also make cancer more susceptible to radiation, according to doctors in Brazil. Their findings are published in the March 1// issue of the International Journal of Radiation

Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology. The reserachers decided to check out data from already published studies to evaluate if adding amifostine to radiation therapy decreased the occurrence of side effects like difficulty in swallowing, dry mouth, lung inflammation, bladder inflammation, problems with the esophagus and inflammation of the mucous membranes. Sometimes these side effects cause significant problems and even force the treatment to be stopped while the patient recovers. The study also wanted to find out if amifostine protected the cancer from radiation. The researchers evaluated the effects of amifostine in 14 randomized, controlled trials in which 1,451 patients were enrolled. These patients were split into two groups, one receiving radiation alone, while the other received radiation as well as amifostine. It was found that contrary to fears, amifostine rendered the tumor more susceptible to radiation and patients on amifostine were more likely to have their cancer completely cured by radiation. But amifostine did have some side effects like nausea and vomiting. "Our research shows that adding amifostine to radiation therapy helps reduce side effects while at the same time making the radiation treatments more effective at killing the cancer cells," said Andre Deeke Sasse, M.D., a radiation oncologist at Nucleo Brasileiro de Oncologia Baseada em Evidencias in Sao Paolo, Brazil. "We recommend that patients undergoing radiation therapy for cancer ask their doctor about adding amifostine to their treatment." For more information on radiation therapy for cancer, please visit Contact: Nick Lashinsky 703-227-0185 American Society for Therapeutic Radiology and Oncology Source: Eurekalert

Related medicine news :

1. Anthrax Spores: Animal Skins on Drums, Renders Vado Diomande, Sick
2. Fibroids unlikely to Turn Cancerous
3. Virus Level could Predict Cervical Cancer Risk
4. Cancer Doctors Okays Controversial Prostate Therapy
5. Potential New Cancer Gene Identified
6. Consensus on "Combination Therapy" for Breast Cancer
7. Cancers of Colon & Rectum linked to Cigarette Smoking
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. The Cancer Rumour mill working over time
10. Cancer drugs in development nearly doubled since 1995
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:

(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Trustify is ... in Washington, DC, hosted by Becky’s Fund, an organization dedicated to ending domestic violence. ... and control back to battered victims and survivors of domestic violence. Trustify is also ...
(Date:12/1/2015)... ... December 01, 2015 , ... On Tuesday ... to NASDAQ to educate the personnel on spinal decompression therapy and offer his ... a nonsurgical procedure. The benefits come from creating negative intradiscal pressure which is ...
(Date:12/1/2015)... , ... December 01, 2015 , ... The Multiple System ... awareness and funds for Multiple System Atrophy (MSA) research, timed today to coincide with ... many things from patients including their ability to work and be productive, to do ...
(Date:12/1/2015)... ... December 01, 2015 , ... The North American Meat ... that meat and poultry play in a healthy, balanced diet. , includes ... visitors can check their “meat IQ,” a section offering straight talk on controversies, ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... World ... the Multi Jar, a container patent that allows for easier packing and organizing of ... US is worth $90 billion," says Scott Cooper, CEO and Creative Director of World ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  A large study of ... tamoxifen while taking an antidepressant found no increased risk ... in The Journal of the National Cancer Institute. ... is a commonly prescribed generic drug taken by women ... a recurrence. Tamoxifen is recommended for five years, but ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
(Date:12/1/2015)... HERNDON, Va. , Dec. 1, 2015 ... (FDA) Drug Supply Chain Security Act (DSCSA) approaches, ... helping small and independent pharmacies comply with looming ... --> InfiniTrak is entering endorsement agreements with ... a pharmacy services administration organization (PSAO) to exclusively ...
Breaking Medicine Technology: